Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804713 · ClinicalTrials.gov registry record · NA
Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits
A NA study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2,017
- Enrollment target
NCT00804713: Completed NA study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
NCT00804713 is a NA study that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 2,017 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00804713, a NA study, has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,017 participants
- Enrollment target
Study Summary
The overall objective of this study is to assess the feasibility and potential impact of using a targeted testing approach and 2 interferon-gamma release assays (IGRA) to screen for latent tuberculosis (TB) infection (LTBI) among military recruits. The current policy of universal application of the Mantoux tuberculin skin test (TST) to screen for LTBI may result in many TST reactions among recruits who are at low risk for LTBI. The central hypothesis is that targeted testing by use of the questionnaire will reduce unnecessary testing of low-risk recruits without affecting the identification of higher-risk recruits. The secondary hypothesis is that many discordant results between the TST and IGRA may be explained by cross-reactivity to non-tuberculous mycobacteria (NTM) with the TST.
Primary Outcome
Risk stratification and test result. Risk was stratified by the use of risk factors identified by questionnaire according to the 5, 10 and 15 mm criteria (CDC Morbidity and Mortality Weekly Report Recommendations and Reports 2000. Targeted Testing for Latent Tuberculosis Infection.) The number of 1803 is used here because that is the number for which valid results were available for all 4 tests. The number presented in each category is the number of participants that had positive results. We
Interventions
- DRUG BST
- DRUG TST
- OTHER QFT
- OTHER T-spot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,017 participants |
| Start Date | 2009-03 |
| Est. Completion | 2022-08 |
| Phase | NA |
What the finished NCT00804713 record still lists
NCT00804713 is an interventional study that assigns participants to a tested intervention. Its 2,017 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher).
The record links to 0 conditions, and to 4 interventions - of which BST is the first listed.
NCT00804713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00804713 about?
NCT00804713 is a clinical study titled "Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits". The overall objective of this study is to assess the feasibility and potential impact of using a targeted testing approach and 2 interferon-gamma release assays (IGRA) to screen for latent tuberculosis (TB) infection (LTBI) among military recruits. The current policy of universal application of the ...
What is the current status of trial NCT00804713?
This trial is currently completed. It is a NA study. The enrollment target is 2,017 participants. The study started on 2009-03. Estimated completion is 2022-08.
What interventions are being tested in trial NCT00804713?
The interventions under investigation include: BST (DRUG), TST (DRUG), QFT (OTHER), T-spot (OTHER).
Who is sponsoring clinical trial NCT00804713?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00804713's enrollment target sits among peer trials
2,017 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia